Cognitive Behavioral Therapy for Childhood Nightmares
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to assess the efficacy of CBT-NC intervention to determine its impact on mental health and suicidality in children ages 6-17. The main aims are: Aim 1: Examine CBT-NC efficacy for improving nightmare distress and frequency in youth with chronic nightmares by comparing the treatment and waitlist group. Aim 2: Examine whether improvements in nightmares relate to fewer mental health problems for youth by determining by comparing the treatment and waitlist group.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but children on prescribed psychotropic medications must be stable for 30 days before enrolling.
What data supports the effectiveness of the treatment Cognitive Behavioral Therapy for Nightmares in Children?
Research shows that Imagery Rehearsal Therapy (IRT), a component of Cognitive Behavioral Therapy for Nightmares, can reduce the frequency and distress of nightmares in children. Studies have found that children who participated in IRT experienced fewer nightmares and less anxiety related to their dreams.12345
Is Cognitive Behavioral Therapy for Nightmares safe for children?
How is Cognitive Behavioral Therapy for Nightmares in Children different from other treatments for childhood nightmares?
Cognitive Behavioral Therapy for Nightmares in Children (CBT-NC), particularly using Imagery Rehearsal Therapy (IRT), is unique because it involves children actively changing the storyline of their nightmares to reduce their frequency and distress. This approach is different from other treatments as it empowers children to use their imagination to alter the nightmare, which can lead to long-lasting improvements in their sleep and anxiety levels.12369
Research Team
Lisa Cromer, PhD
Principal Investigator
University of Tulsa
Tara Buck, MD
Principal Investigator
University of Oklahoma
Eligibility Criteria
This trial is for children aged 6-17 who experience frequent nightmares and are not at immediate risk of self-harm. They must be stable on any psychotropic medications for 30 days, speak English at a minimum 6-year-old level, have a guardian to accompany them, and access to WIFI/data with a camera-enabled device.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Cognitive Behavioral Therapy for Nightmares in Children (CBT-NC) over five sessions
Follow-up
Participants are monitored for changes in mental health and suicidality after treatment
Waitlist Control
Participants in the waitlist control group complete assessments without receiving treatment and are offered treatment after the waitlist period
Treatment Details
Interventions
- Cognitive Behavioral Therapy for Nightmares in Children (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Oklahoma
Lead Sponsor
Dr. Scott Rollins
University of Oklahoma
Chief Executive Officer since 2016
PhD in Immunology from the University of Oklahoma
Dr. Ondria Gleason
University of Oklahoma
Chief Medical Officer
MD from the University of Oklahoma College of Medicine
University of Tulsa
Collaborator